Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to $14.0 million.

  • Perspective Therapeutics' Cash from Investing Activities rose 14705.25% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$125.9 million, marking a year-over-year decrease of 5657.07%. This contributed to the annual value of -$218.9 million for FY2024, which is 99825.22% down from last year.
  • As of Q3 2025, Perspective Therapeutics' Cash from Investing Activities stood at $14.0 million, which was up 14705.25% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Cash from Investing Activities registered a high of $35.2 million during Q4 2021, and its lowest value of -$138.6 million during Q4 2024.
  • In the last 5 years, Perspective Therapeutics' Cash from Investing Activities had a median value of -$188000.0 in 2022 and averaged -$11.7 million.
  • In the last 5 years, Perspective Therapeutics' Cash from Investing Activities surged by 9726153.85% in 2023 and then tumbled by 15563258.43% in 2024.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Cash from Investing Activities stood at $35.2 million in 2021, then crashed by 181.98% to -$28.8 million in 2022, then soared by 99.69% to -$89000.0 in 2023, then tumbled by 155632.58% to -$138.6 million in 2024, then skyrocketed by 110.1% to $14.0 million in 2025.
  • Its Cash from Investing Activities was $14.0 million in Q3 2025, compared to $4.3 million in Q2 2025 and -$5.6 million in Q1 2025.